Nick Page
Plus aucun poste en cours
Fortune : 153 407 $ au 31/03/2024
Profil
Nick Page worked as the Head of Anti Infectives at Novartis UK Ltd.
He then served as the Chief Operations Officer at Oxford Biomedica Plc from 2019 to 2023.
Mr. Page holds an MBA from The Open University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OXFORD BIOMEDICA PLC
0,06% | 21/09/2023 | 60 417 ( 0,06% ) | 153 407 $ | 31/03/2024 |
Anciens postes connus de Nick Page
| Sociétés | Poste | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Chief Operating Officer | 01/10/2023 |
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Nick Page
| The Open University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OXFORD BIOMEDICA PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis UK Ltd.
Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Health Technology |
